Scilex Holding Company - SCLX Net earnings per share (EPS TTM)

Scilex Holding Company is implementing AI-controlled robotic lines for the production of transdermal systems. Revenues are based on the sale of patented pain-relief sprays and patches. Geopolitics and raw material sanctions create risks for the biopharmaceutical sector. The rolling annual net income per share visualizes revenue dynamics, where the value -49.79 shows the latest reading of this indicator.
Analytical breakdowns for Scilex Holding Company, Inc. (SCLX)

This indicator reflects the portion of net income attributable to a single common share over a rolling year, which offsets the impact of issuance and allows for an assessment of real capital generation efficiency. In the defensive analgesic pharmaceutical sector, Scilex Holding Company (SCLX) utilizes this metric to confirm the stability of cash flows driven by patent protection, as clearly demonstrated by the chart of net income per share over the last 12 months.